-transparent.png){kind=logo}
3 mg/day procarbazine hydrochlorate, in a total dose of 300 mg, provoked tumours or raised their number in a variety of rat organs and tissues. 70.8% males and 92.5% females bore tumors against 16.6 and 33% of the controls. It is suggested that the lack of a specific target organ is due to the metabolic conversion of procarbazine to alkylating agents in the liver. The chemical structure, distribution of these agents within the organism and the different organ-specific enzyme activation and inhibition systems are probably responsible for the variable organotropism.
Related Publications
M Bacci, and
A Cavaliere, and
A Amorosi
October 1972,
Archives of ophthalmology (Chicago, Ill. : 1960),
M Bacci, and
A Cavaliere, and
A Amorosi
September 1980,
Toxicology and applied pharmacology,
M Bacci, and
A Cavaliere, and
A Amorosi
October 1952,
The Journal of nutrition,
M Bacci, and
A Cavaliere, and
A Amorosi
January 1982,
Caries research,
M Bacci, and
A Cavaliere, and
A Amorosi
January 1978,
Tumori,
M Bacci, and
A Cavaliere, and
A Amorosi
November 1980,
Journal of environmental pathology and toxicology,
M Bacci, and
A Cavaliere, and
A Amorosi
April 1979,
Life sciences,
M Bacci, and
A Cavaliere, and
A Amorosi
April 1986,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
M Bacci, and
A Cavaliere, and
A Amorosi
January 1978,
Experimental cell biology,
M Bacci, and
A Cavaliere, and
A Amorosi
May 1960,
Endocrinology,
